NCT05374915View on ClinicalTrials.gov

Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 31, 2025

Conditions
Cutaneous Breast Cancer
Interventions
COMBINATION_PRODUCT

REM-001 photodynamic therapy

Infusion of REM-001 (iv) followed by light treatment to treatment field 24 hrs after infusion of REM-001

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Center, New York

10467

Montefiore Einstein Center for Cancer Care, The Bronx

Sponsors
All Listed Sponsors
lead

Kintara Therapeutics, Inc.

INDUSTRY